Precision sedation with novel single syringe multimodal opioid or non-opioid 6-2-2 mixtures.

IF 5.1 2区 医学 Q1 ANESTHESIOLOGY
Zhuang T Fang, Christine Nguyen-Buckley, Tristan Grogan, Alan Zamora, Natalia MacDougall, Theodora Wingert
{"title":"Precision sedation with novel single syringe multimodal opioid or non-opioid 6-2-2 mixtures.","authors":"Zhuang T Fang, Christine Nguyen-Buckley, Tristan Grogan, Alan Zamora, Natalia MacDougall, Theodora Wingert","doi":"10.1016/j.jclinane.2025.112013","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>The purpose of this study is to determine the efficacy and safety of sedation/analgesia using mixtures of propofol, opioids or non-opioid sedatives, and lidocaine or etomidate in one single syringe.</p><p><strong>Design: </strong>A retrospective case review was undertaken.</p><p><strong>Setting: </strong>University outpatient surgical center.</p><p><strong>Patients: </strong>1,376 adult patients undergoing ophthalmic surgery with ocular blocks and monitored anesthesia care were studied.</p><p><strong>Intervention: </strong>The 6 opioid-based mixtures contained 6 portions of propofol, 2 portions of opioid (alfentanil, fentanyl, a combination of alfentanil and fentanyl, or alfentanil and hydromorphone), and 2 portions of lidocaine or ketamine in a single syringe, in a 6:2:2 volume ratio. The non-opioid mixture contained 6 portions of propofol, 2 portions of ketamine, and 2 portions of etomidate. A bolus dose for all mixtures was calculated based on the patient's age and weight: < 40 yr, 1.2 mL/10 kg; 40-59 yr, 1 mL/10 kg; 60-69 yr, 0.8 mL/10 kg; 70-84 yr, 0.6 mL/10 kg; ≥85 yr, 0.5 mL/10 kg, and delivered by hand push or infusion pump intravenously (IV). For patients with a body mass index (BMI) >25, the adjusted weight for dosing (AWFD) was used: AWFD = ideal body weight (IBW) + 0.3 x (Actual weight [AW] - IBW). Ocular blocks were performed when patients reached a moderate level of sedation. Blood pressure (BP), heart rate (HR), oxygen saturation, clinical signs of sedation, responses to blocks, apnea and need for airway support, and recall were recorded.</p><p><strong>Measurement and main results: </strong>91 %-98 % of all patients had no pain during ocular blocks and 98-99 % had no head movement, except in the KE6-2-2 without K10 (bolus only) group. The readiness time was 46-51 s for the opioid groups and 36- 43 s for the non-opioid groups. In the opioid groups, 97 %-99 % had no apnea and 88 %-94 % had no oxygen desaturation, while 99 % had no apnea and 96 % had no oxygen desaturation in the non-opioid groups. Heart rate and blood pressure decreased <10 % in the opioid groups while there was nearly no change in the non-opioid groups.</p><p><strong>Conclusion: </strong>Adjusted for age and weight, the bolus dose of the 6-2-2 mixture met the sedation requirements for ocular blocks in most patients with favorable outcomes and minimal airway or hemodynamic compromise regardless of which mixture was used.</p>","PeriodicalId":15506,"journal":{"name":"Journal of Clinical Anesthesia","volume":"107 ","pages":"112013"},"PeriodicalIF":5.1000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Anesthesia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jclinane.2025.112013","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANESTHESIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: The purpose of this study is to determine the efficacy and safety of sedation/analgesia using mixtures of propofol, opioids or non-opioid sedatives, and lidocaine or etomidate in one single syringe.

Design: A retrospective case review was undertaken.

Setting: University outpatient surgical center.

Patients: 1,376 adult patients undergoing ophthalmic surgery with ocular blocks and monitored anesthesia care were studied.

Intervention: The 6 opioid-based mixtures contained 6 portions of propofol, 2 portions of opioid (alfentanil, fentanyl, a combination of alfentanil and fentanyl, or alfentanil and hydromorphone), and 2 portions of lidocaine or ketamine in a single syringe, in a 6:2:2 volume ratio. The non-opioid mixture contained 6 portions of propofol, 2 portions of ketamine, and 2 portions of etomidate. A bolus dose for all mixtures was calculated based on the patient's age and weight: < 40 yr, 1.2 mL/10 kg; 40-59 yr, 1 mL/10 kg; 60-69 yr, 0.8 mL/10 kg; 70-84 yr, 0.6 mL/10 kg; ≥85 yr, 0.5 mL/10 kg, and delivered by hand push or infusion pump intravenously (IV). For patients with a body mass index (BMI) >25, the adjusted weight for dosing (AWFD) was used: AWFD = ideal body weight (IBW) + 0.3 x (Actual weight [AW] - IBW). Ocular blocks were performed when patients reached a moderate level of sedation. Blood pressure (BP), heart rate (HR), oxygen saturation, clinical signs of sedation, responses to blocks, apnea and need for airway support, and recall were recorded.

Measurement and main results: 91 %-98 % of all patients had no pain during ocular blocks and 98-99 % had no head movement, except in the KE6-2-2 without K10 (bolus only) group. The readiness time was 46-51 s for the opioid groups and 36- 43 s for the non-opioid groups. In the opioid groups, 97 %-99 % had no apnea and 88 %-94 % had no oxygen desaturation, while 99 % had no apnea and 96 % had no oxygen desaturation in the non-opioid groups. Heart rate and blood pressure decreased <10 % in the opioid groups while there was nearly no change in the non-opioid groups.

Conclusion: Adjusted for age and weight, the bolus dose of the 6-2-2 mixture met the sedation requirements for ocular blocks in most patients with favorable outcomes and minimal airway or hemodynamic compromise regardless of which mixture was used.

新型单注射器多模态阿片类药物或非阿片类药物6-2-2混合物的精确镇静。
目的:本研究的目的是确定异丙酚、阿片类或非阿片类镇静剂与利多卡因或依托咪酯单针混合使用镇静/镇痛的有效性和安全性。设计:进行回顾性病例回顾。单位:大学外科门诊中心。患者:1376例成人眼科手术伴眼阻滞及麻醉监护患者。干预:6种阿片类药物混合物中含有6份异丙酚、2份阿片类药物(阿芬太尼、芬太尼、阿芬太尼和芬太尼的组合,或阿芬太尼和氢吗啡酮)和2份利多卡因或氯胺酮,以6:2:2的体积比在单注射器中注射。非阿片类药物混合物含有6份异丙酚,2份氯胺酮和2份依托咪酯。根据患者的年龄和体重计算所有混合物的起始剂量:< 40岁,1.2 mL/10 kg;40-59岁,1ml / 10kg;60-69年,0.8 mL/ 10kg;70-84年,0.6 mL/ 10kg;≥85年,0.5 mL/ 10kg,通过手推或输液泵静脉(IV)给药。对于体重指数(BMI)为bbb25的患者,采用调整给药体重(AWFD): AWFD =理想体重(IBW) + 0.3 x(实际体重[AW] - IBW)。当患者达到中度镇静水平时进行眼阻滞。记录血压(BP)、心率(HR)、血氧饱和度、镇静临床症状、阻滞反应、呼吸暂停和气道支持需求以及回忆。测量和主要结果:除KE6-2-2无K10(仅丸)组外,91% - 98%的患者在眼阻滞期间无疼痛,98% - 99%的患者无头部运动。阿片类药物组和非阿片类药物组的准备时间分别为46 ~ 51 s和36 ~ 43 s。在阿片类药物组中,97% - 99%的患者无呼吸暂停,88% - 94%的患者无氧去饱和,而在非阿片类药物组中,99%的患者无呼吸暂停,96%的患者无氧去饱和。结论:经年龄和体重调整后,大多数患者服用6-2-2混合物时均能满足眼阻滞的镇静要求,结果良好,且无论使用哪种混合物,对气道或血流动力学的损害最小。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.40
自引率
4.50%
发文量
346
审稿时长
23 days
期刊介绍: The Journal of Clinical Anesthesia (JCA) addresses all aspects of anesthesia practice, including anesthetic administration, pharmacokinetics, preoperative and postoperative considerations, coexisting disease and other complicating factors, cost issues, and similar concerns anesthesiologists contend with daily. Exceptionally high standards of presentation and accuracy are maintained. The core of the journal is original contributions on subjects relevant to clinical practice, and rigorously peer-reviewed. Highly respected international experts have joined together to form the Editorial Board, sharing their years of experience and clinical expertise. Specialized section editors cover the various subspecialties within the field. To keep your practical clinical skills current, the journal bridges the gap between the laboratory and the clinical practice of anesthesiology and critical care to clarify how new insights can improve daily practice.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信